Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials
Randomized clinical trials are considered the milestones of clinical research in oncology, and guided the development and approval of new compounds so far. In the last few years, however, molecular and genomic profiling led to a change of paradigm in therapeutic algorithms of many cancer types, with...
Guardado en:
Autores principales: | Raimondo Di Liello, Maria Carmela Piccirillo, Laura Arenare, Piera Gargiulo, Clorinda Schettino, Adriano Gravina, Francesco Perrone |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eabc4ca40ddd4d40aa7f5700bdd4a671 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The opportunity of patient-journey studies for academic clinical research in oncology
por: Raimondo Di Liello, et al.
Publicado: (2021) -
Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis
por: Jessica Liauw, et al.
Publicado: (2021) -
METHODOLOGICAL APPROACHES TO THE ESTIMATION OF INDIVIDUAL OCCUPATIONAL RISK TAKING INTO ACCOUNT INDICATORS OF LIFE QUALITY
por: E. L. Bazarova, et al.
Publicado: (2013) -
Referees Court as an Alternative Way of Settlement of Disputes in the Sphere of Business: History and Present
por: A. A. Barabanov, et al.
Publicado: (2019) - JCO Precision Oncology